miR-181b negatively regulates activation-induced cytidine deaminase in B cells

Journal of Experimental Medicine

Volumn 205, Issue 10, 2008, Pages 2199-2206

  De Yébenes, Virginia G ^a   Belver, Laura ^a   Pisano, David G ^a   González, Susana ^a   Villasante, Aranzazu ^a   Croce, Carlo ^b   He, Lin ^c   Ramiro, Almudena R ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; MICRORNA; MIR 181B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CLASS SWITCH RECOMBINATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MICROARRAY ANALYSIS; MICRORNAS; RNA, MESSENGER;

EID: 53349129731     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20080579     Document Type: Article

References (30)

1. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79-146.
2. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553-563.
3. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102:565-575.
4. Petersen-Mahrt, S.K., R.S. Harris, and M.S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 418:99-103.
5. Maizels, N. 2005. Immunoglobulin gene diversification. Annu. Rev. Genet. 39:23-46.
6. Kuppers, R. 2005. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer. 5:251-262.
7. Ramiro, A.R., M. Jankovic, T. Eisenreich, S. Difilippantonio, S. Chen-Kiang, M. Muramatsu, T. Honjo, A. Nussenzweig, and M.C. Nussenzweig. 2004. AID is required for c-myc/IgH chromosome translocations in vivo. Cell. 118:431-438.
8. Dorsett, Y., D.F. Robbiani, M. Jankovic, B. Reina-San-Martin, T.R. Eisenreich, and M.C. Nussenzweig. 2007. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204:2225-2232.
9. Ramiro, A.R., M. Jankovic, E. Callen, S. Difilippantonio, H.T. Chen, K.M. McBride, T.R. Eisenreich, J. Chen, R.A. Dickins, S.W. Lowe, et al. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature. 440:105-109.
10. Liu, M., J.L. Duke, D.J. Richter, C.G. Vinuesa, C.C. Goodnow, S.H. Kleinstein, and D.G. Schatz. 2008. Two levels of protection for the B cell genome during somatic hypermutation. Nature. 451:841-845.
11. Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R.S. Chaganti, R. Kuppers, and R. Dalla-Favera. 2001. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 412:341-346.
12. Kotani, A., N. Kakazu, T. Tsuruyama, I.M. Okazaki, M. Muramatsu, K. Kinoshita, H. Nagaoka, D. Yabe, and T. Honjo. 2007. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice. Proc. Natl. Acad. Sci. USA. 104:1616-1620.
13. Pasqualucci, L., G. Bhagat, M. Jankovic, M. Compagno, P. Smith, M. Muramatsu, T. Honjo, H.C. Morse III, M.C. Nussenzweig, and R. Dalla-Favera. 2008. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 40:108-112.
14. Kovalchuk, A.L., W. duBois, E. Mushinski, N.E. McNeil, C. Hirt, C.F. Qi, Z. Li, S. Janz, T. Honjo, M. Muramatsu, et al. 2007. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements. J. Exp. Med. 204:2989-3001.
15. Ramiro, A., B.R. San-Martin, K. McBride, M. Jankovic, V. Barreto, A. Nussenzweig, and M.C. Nussenzweig. 2007. The role of activation-induced deaminase in antibody diversification and chromosome translocations. Adv. Immunol. 94:75-107.
16. Perez-Duran, P., V.G. de Yebenes, and A.R. Ramiro. 2007. Oncogenic events triggered by AID, the adverse effect of antibody diversification. Carcinogenesis. 28:2427-2433.
17. He, L., and G.J. Hannon. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:522-531.
18. Garzon, R., M. Fabbri, A. Cimmino, G.A. Calin, and C.M. Croce. 2006. MicroRNA expression and function in cancer. Trends Mol. Med. 12:580-587.
19. Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A.O. Kamphorst, M. Landthaler, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129:1401-1414.
20. Martinez, J., and M. Busslinger. 2007. Life beyond cleavage: the case of Ago2 and hematopoiesis. Genes Dev. 21:1983-1988.
21. McCall, M.N., and P.D. Hodgkin. 1999. Switch recombination and germ-line transcription are division-regulated events in B lymphocytes. Biochim. Biophys. Acta. 1447:43-50.
22. Lewis, B.P., C.B. Burge, and D.P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15-20.
23. Giraldez, A.J., Y. Mishima, J. Rihel, R.J. Grocock, S. Van Dongen, K. Inoue, A.J. Enright, and A.F. Schier. 2006. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science. 312:75-79.
24. Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F.N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity. 28:621-629.
25. Dorsett, Y., K.M. McBride, M. Jankovic, A. Gazumyan, T.H. Thai, D.F. Robbiani, M. Di Virgilio, B.R. San-Martin, G. Heidkamp, T.A. Schwickert, et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity. 28:630-638.
26. Lu, J., G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, et al. 2005. MicroRNA expression profiles classify human cancers. Nature. 435:834-838.
27. Xiao, C., D.P. Calado, G. Galler, T.H. Thai, H.C. Patterson, J. Wang, N. Rajewsky, T.P. Bender, and K. Rajewsky. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 131:146-159.
28. Pekarsky, Y., U. Santanam, A. Cimmino, A. Palamarchuk, A. Efanov, V. Maximov, S. Volinia, H. Alder, C.G. Liu, L. Rassenti, et al. 2006. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66:11590-11593.
29. McBride, K.M., V. Barreto, A.R. Ramiro, P. Stavropoulos, and M.C. Nussenzweig. 2004. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199:1235-1244.
30. Roldo, C., E. Missiaglia, J.P. Hagan, M. Falconi, P. Capelli, S. Bersani, G.A. Calin, S. Volinia, C.G. Liu, A. Scarpa, and C.M. Croce. 2006. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 24:4677-4684.